Last updated 2 months ago
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
1590 patients around the world
Available in Mexico, Argentina, Chile, United States, Spain
Regeneron Pharmaceuticals
21Research sites
1590Patients around the world
This study is for people with
Skin cancer
Melanoma
Requirements for the patient
From 12 Years
All Gender
Medical requirements
Sites
DIABAID – Instituto de asistencia integral en diabetes y patologías crónicas, CABA, Buenos Aires
Recruiting
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Clínica Adventista Belgrano - CABA - Buenos Aires
Recruiting
Instituto de Oncología de Rosario - IOR
Recruiting
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Centro Médico San Roque S.R.L. - Tucumán
Recruiting
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
FAICIC Clinical Research
Recruiting
Investigación Biomédica para el Desarrollo de Fármacos, S.A. de C.V. - Jalisco
Recruiting
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde - Guadalajara
Recruiting
SponsorRegeneron Pharmaceuticals
Study typeInterventional
Conditions
Melanoma
Requirements
From 12 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05352672
